April 16, 2025

CONSORT 2025: Setting New Standards for Clinical Trial Reporting

"Readers should not have to infer what was probably done; they should be told explicitly." This principle drives the comprehensive CONSORT 2025 update, with its 7 new checklist items aimed at improving clinical trial transparency.

Conexiant

April 14, 2025

Inebilizumab Effective for Myasthenia Gravis

CD19+ B-cell-depleting therapy shows significant improvement in function and disease severity in phase III trial of autoimmune neuromuscular disorder.

Conexiant

April 14, 2025

Early RNAi Therapeutic Treatment May Improve Survival in hATTR-PN

"In a disease characterized by unrelenting decline, the results depict the long-term clinical stability afforded by TTR reduction and the long-term safety of patisiran treatment."

Conexiant

April 14, 2025

Semaglutide Users Face Increased Gastroparesis Risk

Study reveals semaglutide users face significantly higher gastroparesis risk compared to bupropion-naltrexone and sleeve gastrectomy, highlighting the need for careful treatment consideration.

Conexiant

April 11, 2025

New Self-Injection Option for gMG, CIDP

A prefilled syringe version of VYVGART Hytrulo, which enables adult patients with generalized myasthenia gravis or chronic inflammatory demyelinating polyneuropathy to self-administer treatment in as little as 20 to 30 seconds, has been approved by the FDA.

Conexiant

April 08, 2025

Distressing Dreams Tied to Early Death, Study

Adults with frequent nightmares face nearly triple the risk of premature mortality.

Conexiant

April 04, 2025

First IgG4-RD Treatment Approved

A humanized monoclonal antibody that targets CD19+ B cells is first FDA-approved treatment for immunoglobulin G4–related disease, reducing flare risk and glucocorticoid use in clinical trials.

Conexiant

April 03, 2025

Youth Vaping: Comparable to Traditional Smoking, Study

Findings suggest that nicotine intake is similar among adolescents who vape and adolescents who smoke, highlighting critical implications for addiction.

Conexiant

April 02, 2025

Ultraprocessed Foods Linked to Arthritis Risk

"Each 10-percentage point higher %TEI from UPFs was associated with a 4% higher likelihood of having any type of arthritis," researchers noted.

Conexiant